DRUGS MADE IN AMERICA ACQUIS (DMAA) Earnings History & Surprises

NASDAQ:DMAA • KYG2847J1040

Current stock price

10.47 USD
-0.04 (-0.38%)
Last:

DMAA Earnings overview

Past quarterly earnings results for DRUGS MADE IN AMERICA ACQUIS (DMAA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 6, 2026

Last Reported

Most Recent
Release Date
Mar 18, 2026
Period
Q3 / 2025
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 - - - -
Q2 2025 - - - -
Q1 2025 - - - -
Q4 2024 - - - -
Q2 2024 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

DMAA Overview DMAA Technical Analysis Report DMAA Fundamental Analysis Report DMAA Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

DRUGS MADE IN AMERICA ACQUIS / DMAA Earnings FAQ

What is the most recent earnings date for DMAA stock?

DRUGS MADE IN AMERICA ACQUIS (DMAA) last reported earnings on 3/18/2026.

Can you provide information on whether DRUGS MADE IN AMERICA ACQUIS beat earnings estimates in the last quarter?

DRUGS MADE IN AMERICA ACQUIS (DMAA) missed EPS estimates and missed revenue estimates in the most recent quarter.